Aytu BioScience, Inc. (AYTU) Social Stream
AYTU BIOPHARMA INC (AYTU) Price Targets From Analysts
Use the tables below to see what analysts covering AYTU BIOPHARMA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-15 | 1 | $11 | $11 | $11 | $2.73 | 302.93% |
| 2022-04-28 | 2 | $11 | $11 | $11 | $2.73 | 302.93% |
| 2022-05-17 | 2 | $11 | $5 | $8 | $2.73 | 193.04% |
| 2022-11-16 | 1 | $120 | $100 | $110 | $2.73 | 3929.3% |
| 2023-05-12 | 2 | $120 | $20 | $70 | $2.73 | 2464.1% |
| 2023-05-31 | 2 | $20 | $20 | $20 | $2.73 | 632.6% |
| 2023-08-09 | 2 | $20 | $5 | $12.5 | $2.73 | 357.88% |
| 2023-09-08 | 1 | $5 | $5 | $5 | $2.73 | 83.15% |
Price Target Last Issued November 16, 2022
The Trend in the Analyst Price Target
AYTU's average price target has moved down $11.5 over the prior 26 months.
AYTU reports an average of 1,118.27% for its upside potential over the past 28 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-12 | 2 | 120 | 20 | 70 | 1.840 | 3704.35% |
| 2023-05-31 | 2 | 20 | 20 | 20 | 1.670 | 1097.6% |
| 2023-05-31 | 1 | 20 | 20 | 20 | 1.670 | 1097.6% |
| 2023-08-09 | 2 | 5 | 5 | 5 | 1.809 | 176.4% |
| 2023-09-08 | 1 | 5 | 5 | 5 | 1.650 | 203.03% |
AYTU Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
AYTU's average broker recommendation rating improved by 0 over the prior 30 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how AYTU BIOPHARMA INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 22.64% of that group.
- AYTU BIOPHARMA INC's variance in analysts' estimates is lower than -288.24% of all US stocks.
- In terms of how AYTU BIOPHARMA INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1100.2% of that group.
- AYTU has a higher average analyst price target than 419.74% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AYTU BIOPHARMA INC are SCYX, PTN, and OCUP.
View All Top Stocks by Price Target
Make investment decisions regarding AYTU using the data that counts. Try POWR Ratings for free.